Jump to content

Magnesium pidolate: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)
No edit summary
 
(11 intermediate revisions by 10 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox
{{Drugbox
| verifiedrevid = 400295046
| verifiedrevid = 400295046
Line 25: Line 26:


<!--Identifiers-->
<!--Identifiers-->
| CAS_number =
| CAS_number = 135701-98-3
| ATC_prefix = A12
| ATC_prefix = A12
| ATC_suffix = CC08
| ATC_suffix = CC08
Line 33: Line 34:
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 8014340
| ChemSpiderID = 8014340
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = V5PC588N7G


<!--Chemical data-->
<!--Chemical data-->
| C=10 | H=12 | N=2 | Mg=1 | O=6
| C=10 | H=12 | N=2 | Mg=1 | O=6
| molecular_weight = 280.517 g/mol
| smiles = [Mg+2].[O-]C(=O)C1NC(=O)CC1.[O-]C(=O)C1NC(=O)CC1
| smiles = [Mg+2].[O-]C(=O)C1NC(=O)CC1.[O-]C(=O)C1NC(=O)CC1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
Line 44: Line 46:
}}
}}


'''Magnesium pidolate''', the [[magnesium]] [[salt (chemistry)|salt]] of [[pidolic acid]] (pyroglutamic acid), is a [[Dietary mineral|mineral supplement]].
'''Magnesium pidolate''', the [[magnesium]] [[salt (chemistry)|salt]] of [[pidolic acid]] (also known as pyroglutamic acid), is a [[Dietary mineral|mineral supplement]], which contains 8.6% magnesium w/w.


==External links==
==External links==
* {{cite journal |vauthors=De Franceschi L, Bachir D, Galacteros F, etal |title=Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease |journal=Br. J. Haematol. |volume=108 |issue=2 |pages=284–9 |year=2000 |pmid=10691856 |doi=10.1046/j.1365-2141.2000.01861.x}}
* {{cite journal |vauthors=De Franceschi L, Bachir D, Galacteros F, etal |title=Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease |journal=Br. J. Haematol. |volume=108 |issue=2 |pages=284–9 |year=2000 |pmid=10691856 |doi=10.1046/j.1365-2141.2000.01861.x|s2cid=36974114 |doi-access= }}


{{Mineral supplements}}
{{Mineral supplements}}
{{gastrointestinal-drug-stub}}

[[Category:Magnesium compounds]]
[[Category:Magnesium compounds]]
[[Category:Salts and esters of carboxylic acids]]
[[Category:Salts of carboxylic acids]]


{{gastrointestinal-drug-stub}}

Latest revision as of 08:04, 19 April 2024

Magnesium pidolate
Clinical data
AHFS/Drugs.comConsumer Drug Information
ATC code
Identifiers
  • Magnesium 5-oxopyrrolidine-2-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.080.955 Edit this at Wikidata
Chemical and physical data
FormulaC10H12MgN2O6
Molar mass280.519 g·mol−1
3D model (JSmol)
  • [Mg+2].[O-]C(=O)C1NC(=O)CC1.[O-]C(=O)C1NC(=O)CC1
  • InChI=1S/2C5H7NO3.Mg/c2*7-4-2-1-3(6-4)5(8)9;/h2*3H,1-2H2,(H,6,7)(H,8,9);/q;;+2/p-2 checkY
  • Key:JQAACYUZYRBHGG-UHFFFAOYSA-L checkY
  (verify)

Magnesium pidolate, the magnesium salt of pidolic acid (also known as pyroglutamic acid), is a mineral supplement, which contains 8.6% magnesium w/w.

[edit]
  • De Franceschi L, Bachir D, Galacteros F, et al. (2000). "Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease". Br. J. Haematol. 108 (2): 284–9. doi:10.1046/j.1365-2141.2000.01861.x. PMID 10691856. S2CID 36974114.